Research map: The impact of expanded access to germline high penetrance genetic testing for women with a new diagnosis of invasive breast cancer or high-grade DCIS

Back to the article

Papers in this map

  1. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies · Erik B von Elm · 2007 · 20683 citations · Cited by this paper
  2. Evaluating the Efficacy of Neoadjuvant Endocrine Therapy in HER2-Low Versus HER2-Negative Breast Cancer · 2026 · Related
  3. Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation · Mark E. Robson · 2017 · 3330 citations · Cited by this paper
  4. Global Burdens and Trends of Breast Cancer Attributable to Dietary and Metabolic Risks: A 30-Year Analysis With Projections to 2050, Including Males and Females · 2026 · Related
  5. Talazoparib in Patients with Advanced Breast Cancer and a Germline BRCA Mutation · Jennifer Keating Litton · 2018 · 2203 citations · Cited by this paper
  6. Effect of Treatment Sequencing in Older Adults With Early Breast Cancer. Insights From a Retrospective Single-Institution Cohort · 2026 · Related
  7. Adjuvant Olaparib for Patients with BRCA1 - or BRCA2 -Mutated Breast Cancer · Andrew N.J. Tutt · 2021 · 1745 citations · Cited by this paper
  8. Patients With Luminal Breast Carcinoma: The State of the Field in Proteomic and Proteogenomic Molecular Subtyping · 2026 · Related
  9. Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers With Cancer Risk and Mortality · Susan M. Domchek · 2010 · 1505 citations · Cited by this paper
  10. Methodological Concerns Regarding the Assessment of Breast Cancer Risk Following Gender-Affirming Care · 2026 · Related
  11. Efficacy of Bilateral Prophylactic Mastectomy in Women with a Family History of Breast Cancer · Lynn C. Hartmann · 1999 · 1429 citations · Cited by this paper
  12. Prevalence and Prognostic Implications of Circulating Tumor Cells Among Patients Undergoing Neoadjuvant Chemotherapy for Early-Stage Breast Cancer · 2026 · Related
  13. Familial Risk and Heritability of Cancer Among Twins in Nordic Countries · Lorelei Ann Mucci · 2016 · 971 citations · Cited by this paper
  14. Association of Regional Anesthesia With Reduced Post-discharge Opioid Prescriptions Following Immediate Autologous Breast Reconstruction: An ACS-NSQIP Analysis · 2026 · Related
  15. A Population-Based Study of Genes Previously Implicated in Breast Cancer · Chunling Hu · 2021 · 899 citations · Cited by this paper
  16. Evaluation of Absorbable Hemostatic Powder on Post-operative Outcomes in Patients Undergoing Mastectomy · 2026 · Related
  17. Breast-Cancer Risk in Families with Mutations in PALB2 · Antonis C. Antoniou · 2014 · 865 citations · Cited by this paper
  18. Feasibility of Same Day Mastectomy Discharge in a Safety Net Hospital in Memphis, TN · 2026 · Related
  19. Germline BRCA mutation and outcome in young-onset breast cancer (POSH): a prospective cohort study · Ellen Copson · 2018 · 510 citations · Cited by this paper
  20. CTSG suppresses breast cancer progression by inhibiting the EGFR/ERK signaling pathway and enhancing CD8⁺ T cell activation · 2026 · Related
  21. Genetic Testing and Results in a Population-Based Cohort of Breast Cancer Patients and Ovarian Cancer Patients · Allison W. Kurian · 2019 · 396 citations · Cited by this paper
  22. Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriers · T.C. van Sprundel · 2005 · 292 citations · Cited by this paper
  23. A systematic review of the international prevalence of BRCA mutation in breast cancer · Nigel Armstrong · 2019 · 260 citations · Cited by this paper
  24. Effectiveness of Prophylactic Surgeries in BRCA1 or BRCA2 Mutation Carriers: A Meta-analysis and Systematic Review · Xiao Li · 2016 · 241 citations · Cited by this paper
  25. Contralateral prophylactic mastectomy improves the outcome of selected patients undergoing mastectomy for breast cancer · Elizabeth A. Peralta · 2000 · 199 citations · Cited by this paper
  26. Bilateral Risk-Reduction Mastectomy in BRCA1 and BRCA2 Mutation Carriers: A Meta-analysis · Francesca De Felice · 2015 · 93 citations · Cited by this paper
  27. Impact that Timing of Genetic Mutation Diagnosis has on Surgical Decision Making and Outcome for BRCA1/BRCA2 Mutation Carriers with Breast Cancer · Akiko Chiba · 2016 · 70 citations · Cited by this paper
  28. Preoperative genetic testing affects surgical decision making in breast cancer patients · Elizabeth Lokich · 2014 · 45 citations · Cited by this paper
  29. Preoperative genetic testing impacts surgical decision making in BRCA mutation carriers with breast cancer: a retrospective cohort analysis · Siddhartha Yadav · 2017 · 45 citations · Cited by this paper
  30. Understanding genetic variations associated with familial breast cancer · Manjusha Pal · 2024 · 45 citations · Cited by this paper
  31. Population-based germline breast cancer gene association studies and meta-analysis to inform wider mainstream testing · Charlie F Rowlands · 2024 · 40 citations · Cited by this paper
  32. Universal genetic testing for women with newly diagnosed breast cancer in the context of multidisciplinary team care · Dilanka L De Silva · 2023 · 34 citations · Cited by this paper
  33. Universal Genetic Testing for Newly Diagnosed Invasive Breast Cancer · Zoulikha Rezoug · 2024 · 28 citations · Cited by this paper
  34. Uptake and efficacy of bilateral risk reducing surgery in unaffected female BRCA1 and BRCA2 carriers · Ruta Marcinkute · 2021 · 25 citations · Cited by this paper
  35. Does mainstream BRCA testing affect surgical decision-making in newly-diagnosed breast cancer patients? · Quratul Ain · 2022 · 24 citations · Cited by this paper
  36. Breast cancer germline multigene panel testing in mainstream oncology based on clinical–public health utility: ESMO Precision Oncology Working Group recommendations · Clare Turnbull · 2025 · 24 citations · Cited by this paper
  37. Universal Germline-Genetic Testing for Breast Cancer: Implementation in a Rural Practice and Impact on Shared Decision-Making · Charles Hendrix Shelton · 2023 · 16 citations · Cited by this paper
  38. Clinical Outcomes for BRCA Pathogenic Variant Carriers With Breast Cancer Undergoing Breast Conservation · Kerollos Nashat Wanis · 2024 · 11 citations · Cited by this paper
  39. Examining the uptake of predictive BRCA testing in the UK; findings and implications · Antony Paul Martin · 2020 · 10 citations · Cited by this paper

Source: OpenAlex (CC0)